Teladoc Health Statistics
Total Valuation
Teladoc Health has a market cap or net worth of $1.36 billion. The enterprise value is $1.71 billion.
Important Dates
The next estimated earnings date is Wednesday, October 29, 2025, after market close.
| Earnings Date | Oct 29, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Teladoc Health has 176.69 million shares outstanding. The number of shares has increased by 3.77% in one year.
| Current Share Class | 176.69M |
| Shares Outstanding | 176.69M |
| Shares Change (YoY) | +3.77% |
| Shares Change (QoQ) | +1.01% |
| Owned by Insiders (%) | 1.10% |
| Owned by Institutions (%) | 72.67% |
| Float | 174.74M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.52 |
| Forward PS | 0.53 |
| PB Ratio | 0.95 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 4.65 |
| P/OCF Ratio | 4.47 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 90.69, with an EV/FCF ratio of 5.87.
| EV / Earnings | n/a |
| EV / Sales | 0.67 |
| EV / EBITDA | 90.69 |
| EV / EBIT | n/a |
| EV / FCF | 5.87 |
Financial Position
The company has a current ratio of 2.67, with a Debt / Equity ratio of 0.73.
| Current Ratio | 2.67 |
| Quick Ratio | 2.27 |
| Debt / Equity | 0.73 |
| Debt / EBITDA | 33.35 |
| Debt / FCF | 3.55 |
| Interest Coverage | -8.07 |
Financial Efficiency
Return on equity (ROE) is -14.18% and return on invested capital (ROIC) is -4.13%.
| Return on Equity (ROE) | -14.18% |
| Return on Assets (ROA) | -3.57% |
| Return on Invested Capital (ROIC) | -4.13% |
| Return on Capital Employed (ROCE) | -7.36% |
| Revenue Per Employee | $462,231 |
| Profits Per Employee | -$37,701 |
| Employee Count | 5,500 |
| Asset Turnover | 0.79 |
| Inventory Turnover | 20.70 |
Taxes
| Income Tax | -25.00M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -4.82% in the last 52 weeks. The beta is 1.85, so Teladoc Health's price volatility has been higher than the market average.
| Beta (5Y) | 1.85 |
| 52-Week Price Change | -4.82% |
| 50-Day Moving Average | 7.71 |
| 200-Day Moving Average | 8.63 |
| Relative Strength Index (RSI) | 51.79 |
| Average Volume (20 Days) | 4,285,875 |
Short Selling Information
The latest short interest is 23.02 million, so 13.03% of the outstanding shares have been sold short.
| Short Interest | 23.02M |
| Short Previous Month | 24.01M |
| Short % of Shares Out | 13.03% |
| Short % of Float | 13.18% |
| Short Ratio (days to cover) | 3.41 |
Income Statement
In the last 12 months, Teladoc Health had revenue of $2.54 billion and -$207.36 million in losses. Loss per share was -$1.19.
| Revenue | 2.54B |
| Gross Profit | 1.79B |
| Operating Income | -183.49M |
| Pretax Income | -997.92M |
| Net Income | -207.36M |
| EBITDA | 18.88M |
| EBIT | -183.49M |
| Loss Per Share | -$1.19 |
Full Income StatementBalance Sheet
The company has $679.62 million in cash and $1.04 billion in debt, giving a net cash position of -$355.47 million or -$2.01 per share.
| Cash & Cash Equivalents | 679.62M |
| Total Debt | 1.04B |
| Net Cash | -355.47M |
| Net Cash Per Share | -$2.01 |
| Equity (Book Value) | 1.42B |
| Book Value Per Share | 8.05 |
| Working Capital | 671.50M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $303.43 million and capital expenditures -$11.72 million, giving a free cash flow of $291.71 million.
| Operating Cash Flow | 303.43M |
| Capital Expenditures | -11.72M |
| Free Cash Flow | 291.71M |
| FCF Per Share | $1.65 |
Full Cash Flow StatementMargins
Gross margin is 70.26%, with operating and profit margins of -7.22% and -8.16%.
| Gross Margin | 70.26% |
| Operating Margin | -7.22% |
| Pretax Margin | -9.14% |
| Profit Margin | -8.16% |
| EBITDA Margin | 0.74% |
| EBIT Margin | -7.22% |
| FCF Margin | 11.47% |
Dividends & Yields
Teladoc Health does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -3.77% |
| Shareholder Yield | -3.77% |
| Earnings Yield | -15.28% |
| FCF Yield | 21.50% |
Dividend DetailsAnalyst Forecast
The average price target for Teladoc Health is $9.80, which is 27.77% higher than the current price. The consensus rating is "Buy".
| Price Target | $9.80 |
| Price Target Difference | 27.77% |
| Analyst Consensus | Buy |
| Analyst Count | 17 |
| Revenue Growth Forecast (5Y) | 2.98% |
| EPS Growth Forecast (5Y) | -33.47% |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Teladoc Health has an Altman Z-Score of -6.34 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -6.34 |
| Piotroski F-Score | 4 |
